Chutter Jessica Caroline 4

What Happened

• Jessica Caroline Chutter, a director of PTC Therapeutics (PTCT), was granted a package of equity awards on March 24, 2026. The awards total 13,704 shares/equivalents and were recorded as acquisitions (code A) at $0.00 per share (no cash paid on grant). Breakdown: 4,000 restricted stock units (RSUs); 3,333 RSUs with split near-term vesting; 3,475 stock options (derivative); and 2,896 stock options (derivative).

Key Details

• Transaction date: March 24, 2026; Form 4 filed March 26, 2026 (appears timely).
• Grants (all at $0.00): 4,000 RSUs (F1); 3,333 RSUs with split vesting (F2); 3,475 options vesting monthly over 36 months (F3); 2,896 options vesting monthly over 10 months (F4).
• Total awards: 13,704 shares/options.
• Shares owned after transaction: not disclosed in the provided filing details.
• Transaction code: A = Award/Grant. No sale, purchase, or tax-withholding reported in the provided entries.

Context

• RSUs convert to shares upon vesting; the 4,000 RSUs vest in three equal annual installments starting March 24, 2027 (F1). The 3,333 RSUs vest 1,000 shares on June 2, 2026 and the remaining 2,333 on January 2, 2027 (F2). The option grants vest monthly (one over 36 months starting April 24, 2026; the other over 10 months starting April 2, 2026) and are not immediately exercisable (F3, F4). Director equity grants are common compensation and do not by themselves indicate buying or selling sentiment.